Contributors

Dr. Suresh S. Ramalingam

Dr. Suresh Ramalingam is a board-certified medical oncologist specializing in small cell and non-small cell lung cancer. He serves as executive director of Winship Cancer Institute of Emory University, as well as associate vice president for cancer of Woodruff Health Sciences Center, and holds the Roberto C. Goizueta Distinguished Chair for Cancer Research.

Latest:

Tagrisso Therapy Elicits Wave of New Therapeutic Approaches in NSCLC

Dr. Suresh Ramalingam discussed how the LAURA findings support the role of Tagrisso as a backbone therapy across multiple settings in EGFR-mutated NSCLC.

Johanna Rauhala

Latest:

When Spring Is Not Assured: Living In The Terminal Liminal

Dr Rebecca Rhee

Dr Rebecca Rhee works at Maimonides Medical Center where she is a colorectal surgeon and program director of the general surgery residence.

Latest:

Expert Offers Surveillance, Lifestyle Guidance After CRC, Anal Cancer

Avoiding smoking, eating a high-fiber diet and routine screenings are key to reducing the risk of recurrence in colorectal or anal cancer.

Jonathan W. Riess, MD, MS, UC Davis Comprehensive Cancer Center

Latest:

ALK+ Metastatic Non-Small Cell Lung Cancer: The Importance of Biomarker Testing

Dr. Estelamari Rodriguez

Dr. Estelamari Rodriguez is a triple board-certified hematologist and oncologist at Sylvester Comprehensive Cancer Center.

Latest:

Honoring a Healer: Personal Care With National Impact

This is a joint nomination by Camille Moses and Dr. Estelamari Rodriguez.

LaShae D. Rolle

Latest:

How Physical Activity Impacts Cancer Care Outcomes

LaShae D. Rolle discusses how maintaining physical activity during active breast cancer treatment may impact a patients mental and emotional well-being.

Kelley Rone, APRN, DNP, Mayo Clinic

Latest:

Improving Colorectal Cancer Management

Latest:

Jumping Out of Planes, Getting Tattoos and Just Being Me After Cancer

A dual cancer diagnosis rewired how I live, love, and show up in the world — with presence, purpose, and unapologetic passion.

Latest:

FDA Grants Breakthrough Device Status to MRD Test in Colorectal Cancer

The FDA granted breakthrough device designation to Quest Diagnostics’ Haystack MRD test for patients with stage 2 colorectal cancer after surgery.

Melody Saberon Ybarra

Melody Saberon Ybarra is a survivor of epithelial sarcoma and liver sarcoma.

Latest:

Going Through Cancer as a Young Adult Shaped My Outlook on Life

I went through two grueling bouts of cancer when I was a young adult, which drastically shaped my life.

Latest News

Looking Back on the Shock of a Multiple Myeloma Diagnosis

Beyond the Diagnosis: A Stage-by-Stage Guide to Multiple Myeloma Treatment

FDA Approves Bosaya and Aukelso Biosimilars for Solid Tumor Care

How to Access Support Resources for Rare Cancers

View More Latest News